[HTML][HTML] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC pulmonary …, 2022 - Springer
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

[HTML][HTML] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC Pulmonary …, 2022 - ncbi.nlm.nih.gov
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

[PDF][PDF] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano, N Takeda, K Fukumitsu… - scholar.archive.org
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary brosis …

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.

K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC Pulmonary …, 2022 - europepmc.org
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano… - BMC pulmonary …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC Pulmonary …, 2022 - search.proquest.com
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

[HTML][HTML] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano… - BMC …, 2022 - bmcpulmmed.biomedcentral.com
The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a marker for
sarcopenia, but has not been studied in patients with idiopathic pulmonary fibrosis (IPF) …

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano, N Takeda, K Fukumitsu… - 2022 - researchsquare.com
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC pulmonary …, 2022 - pure.fujita-hu.ac.jp
Background: The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.

K Fujita, H Ohkubo, A Nakano… - BMC Pulmonary …, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> The serum creatinine/cystatin C (Cr/CysC)
ratio has attracted attention as a marker for sarcopenia, but has not been studied in patients …